blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3056516

EP3056516 - INHIBITORS OF COMPLEMENT ACTIVATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.07.2017
Database last updated on 09.07.2024
FormerThe application has been published
Status updated on  27.03.2017
Most recent event   Tooltip14.07.2017Application deemed to be withdrawnpublished on 16.08.2017  [2017/33]
Applicant(s)For all designated states
GENENTECH, INC.
1 DNA Way
South San Francisco, CA 94080-4990 / US
[2016/33]
Inventor(s)01 / FUNG, Michael Sek Chung
922 Beacon Square Court 425
Gaithersburg, MD 20878 / US
02 / RY SUN, Cecily
1 Long Dong Road
Tomson Garden N2, Apt A3-501
201203 Pudong / CN
03 / SUN, William N.
1 Long Dong Road, Tomson Garden N2, Apt A3-501
201203 Pudong / CN
 [2016/33]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2016/33]
Application number, filing date15185734.919.02.1999
[2016/33]
Priority number, dateUS19980075328P20.02.1998         Original published format: US 75328 P
[2016/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3056516
Date:17.08.2016
Language:EN
[2016/33]
Search report(s)(Supplementary) European search report - dispatched on:EP15.07.2016
ClassificationIPC:C07K16/40, A61K39/395, C12N5/12, A61K38/00, C07K16/18, A61P41/00, // A61K39/00
[2016/33]
CPC:
C07K16/40 (EP,US); A61K39/395 (KR); A61P29/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P41/00 (EP);
A61P43/00 (EP); A61P7/00 (EP); A61P9/00 (EP);
C07K16/18 (EP,US); A61K2039/505 (EP,US); A61K38/00 (EP,US);
C07K2317/24 (EP,US); C07K2317/55 (EP,US); C07K2317/76 (EP,US);
C07K2319/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2016/33]
TitleGerman:HEMMER DER KOMPLEMENTÄR AKTIVIERUNG[2016/33]
English:INHIBITORS OF COMPLEMENT ACTIVATION[2016/33]
French:INHIBITEURS D'ACTIVATION COMPLÉMENTAIRE[2016/33]
Biological materialThis application mentions deposited biological material, check the file for details
Examination procedure18.02.2017Application deemed to be withdrawn, date of legal effect  [2017/33]
28.03.2017Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2017/33]
Parent application(s)   TooltipEP08018816.2  / EP2033659
EP10182251.8  / EP2277920
EP14168816.8  / EP2848634
EP99909512.8  / EP1054693
Divisional application(s)EP17156521.1
Fees paidRenewal fee
13.01.2016Renewal fee patent year 03
13.01.2016Renewal fee patent year 04
13.01.2016Renewal fee patent year 05
13.01.2016Renewal fee patent year 06
13.01.2016Renewal fee patent year 07
13.01.2016Renewal fee patent year 08
13.01.2016Renewal fee patent year 09
13.01.2016Renewal fee patent year 10
13.01.2016Renewal fee patent year 11
13.01.2016Renewal fee patent year 12
13.01.2016Renewal fee patent year 13
13.01.2016Renewal fee patent year 14
13.01.2016Renewal fee patent year 15
13.01.2016Renewal fee patent year 16
13.01.2016Renewal fee patent year 17
13.01.2016Renewal fee patent year 18
07.02.2017Renewal fee patent year 19
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]  - NIEMANN M A ET AL, "The use of monoclonal antibodies as probes of the three-dimensional structure of human complement factor D", JOURNAL OF IMMUNOLOGY, AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (19840101), vol. 132, no. 2, ISSN 0022-1767, pages 809 - 815, XP002313043 [A] 1-15 * § discussion *
 [XI]  - PASCUAL M ET AL, "A MONOCLONAL ANTIBODY WHICH BLOCKS THE FUNCTION OF FACTOR D OF HUMAN COMPLEMENT", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, (19900101), vol. 127, ISSN 0022-1759, pages 263 - 269, XP002920517 [X] 1,2,6,14 * page 266 - column 2, paragraphs 1,2 * [I] 3-5,7-13,15

DOI:   http://dx.doi.org/10.1016/0022-1759(90)90077-9
by applicantUS4946778
 US5225539
 US5530101
    - V.M. HOLERS, Clinical Immunology: Principles and Practice, MOSBY PRESS, (1996), pages 363 - 391
    - P.H. LESAVRE; H.J. MÜLLER-EBERHARD, J. EXP. MED., (1978), vol. 148, pages 1498 - 1510
    - J.E. VOLANAKIS ET AL., NEW ENG. J. MED., (1985), vol. 312, page 395401
    - Y. WANG ET AL., PROC. NATL. ACAD. SCI., (1996), vol. 93, pages 8563 - 8568
    - Y. WANG ET AL., PROC. NATL. ACAD. SCI., (1995), vol. 92, pages 8955 - 8959
    - C.S. RINDER, J. CLIN. INVEST., (1995), vol. 96, pages 1564 - 1572
    - T.J. KROSHUS ET AL., TRANSPLANTATION, (1995), vol. 60, pages 1194 - 1202
    - J. W. HOMEISTER ET AL., J. IMMUNOL., (1993), vol. 150, pages 1055 - 1064
    - H.F. WEISMAN ET AL., SCIENCE, (1990), vol. 249, pages 146 - 151
    - E.A. AMSTERDAM, AM. J. PHYSIOL., (1995), vol. 268, pages H448 - H457
    - R. RABINOVICI ET AL., J. IMMUNOL, (1992), vol. 149, pages 1744 - 1750
    - B.P. MORGAN, EUR. J. CLIN. INVEST., (1994), vol. 24, pages 219 - 228
    - G. KOHIER; C. MILSTEIN, NATURE, (1975), vol. 256, pages 495 - 497
    - S.M. CANFIELD; S.L. MORRISON, J. EXP. MED., (1991), vol. 173, pages 1483 - 1491
    - Y.XU, J. BIOI CHEM., (1994), vol. 269, pages 3468 - 3474
    - V.L. PULITO ET AL., J. IMMUNOL., (1996), vol. 156, pages 2840 - 2850
    - L. RIECHMANN ET AL., NATURE, (1988), vol. 332, pages 323 - 327
    - M.J. EVANS ET AL., J. IMMUNOL. METH., (1995), vol. 184, pages 123 - 138
    - J.W. HOMEISTER ET AL., J. IMMUNOL, (1993), vol. 150, pages 1055 - 1064
    - S.K. DATTA, METH. ENZYMOL., (1988), vol. 162, pages 385 - 442
    - D.J. SALVANT; A.V. CYBULSKY, METH. ENZYMOL., (1988), vol. 162, pages 421 - 461
    - R. RABINOVICI ET AL., J. LMMUNOL., (1992), vol. 149, pages 1744 - 1750
    - M.S. MULLIGAN ET AL., J. IMMUNOL., (1992), vol. 148, pages 1479 - 1485
    - C.S. RINDER ET AL., J. CLIN. INVEST., (1995), vol. 96, pages 1564 - 1572
    - K. WHALEY ET AL., Complement: A Practical Approach, OXFORD UNIVERSITY PRESS, (1997), pages 19 - 47
    - R.T. WHITE, J. BIOL. CHEM., (1992), vol. 267, pages 9210 - 9213
    - J.E. VOLANAKIS ET AL., The Human Complement System in Health and Disease, MARCEL DEKKER, (1998), pages 49 - 81
    - S.V.L. NARAYANA ET AL., J. MOL. BIOL., (1994), vol. 235, pages 695 - 708
    - J.E. VOLANAKIS ET AL., PROTEIN SCI., (1996), vol. 5, pages 553 - 564
    - CHEN; PLATSUCAS, SCAND. J. /MMUNOL., (1992), vol. 35, pages 539 - 549
    - J.L. PLATT ET AL., TRANSPLANTATION, (1991), vol. 52, pages 937 - 947
    - T. TAKAHASHI, LMMUNOL RES., (1997), vol. 16, pages 273 - 297
    - P.S. JOHNSTON ET AL., TRANSPLANT. PROC., (1991), vol. 23, pages 877 - 879
    - M.R. GRALINSKI ET AL., IMMUNOPHARMACOLOGY, (1996), vol. 34, pages 79 - 88
    - S.C. MAKRIDES, PHARMACOLOGICAL REV., (1998), vol. 50, pages 59 - 87
    - J.K. KIRKLIN ET AL., J. THORAC. CARDIOVASC. SURG., (1983), vol. 86, pages 845 - 857
    - L. NILSSON ET AL., SCAND. J. THORAC. CARDIOVASC. SURG., (1988), vol. 22, pages 51 - 53
    - P.W. WEERWIND ET AL., J. THORAC. CARDIOVASC. SURG., (1995), vol. 110, pages 1633 - 1641
    - P. HASLAM ET AL., ANAESTHESIA, (1980), vol. 25, pages 22 - 26
    - A. SALAMA ET AL., N. ENG. J. MED., (1980), vol. 318, pages 408 - 414
    - J. STEINBERG ET AL., J. THORAC. CARDIOVASC. SURG., (1993), vol. 106, pages 1008 - 1016
    - D. ROYSTON, J. CARDIOTHORAC. VASC. ANESTH., (1997), vol. 11, pages 341 - 354
    - M.P. FLETCHER ET AL., AM. J. PHYSIOL., (1993), vol. 265, pages H1750 - H1761
    - T. WIEDMER ET AL., BLOOD, (1991), vol. 78, pages 2880 - 2886
    - K.E. FOREMAN ET AL., J. CLIN. INVEST., (1994), vol. 94, pages 1147 - 1155
    - K. HARTMANN ET AL., BLOOD, (1997), vol. 89, pages 2868 - 2870
    - Y. KUBOTA, J. DERMATOL., (1992), vol. 19, pages 19 - 26
    - T.J. WILLIAMS, AGENTS ACTIONS, (1983), vol. 13, pages 451 - 455
    - J. KAPPELAMYER ET AL., CIRC. RES., (1993), vol. 72, pages 1075 - 1081
    - N. MOAT ET AL., ANN. THORAC. SURG., (1993), vol. 56, pages 1509 - 1514
    - C.S. RINDER ET AL., J. CLIN. INVEST.,, (1995), vol. 96, pages 1564 - 1572
    - V.L. JR. HENNESY ET AL., AM. J. PHYSIOL., (1977), vol. 2132, pages H622 - H628
    - Y. WACHTFOGEL ET AL., J. LAB. CLIN. MED., (1985), vol. 105, pages 601 - 607
    - C.S. RINDER ET AL., J. LAB. CLIN. MED.
    - P.G. LOUBSER, PERFUSION, (1987), vol. 2, pages 219 - 222
    - C.S. RINDER ET AL., PERFUSION
    - S.T. BAKSAAS ET AL., PERFUSION, (1998), vol. 13, pages 429 - 436
 WO1998GB01473
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.